Greene v. Safeway, Inc.
District Court, N.D. California
1Opinion
STRICT SC CSDM rien “OURS OUT Oa Pb22 UNITED STATES JUDICIAL PANEL .. on 8.0, OF NY MULTIDISTRICT LITIGATION IN RE: ACETAMINOPHEN - ASD/ADHD MDL No. 3643 PRODUCTS LIABILITY LITIGATION TRANSFER ORDER Before the Panel:* Plaintiff in one action (Thompson) moves under 28 U.S.C, § 1407 to centralize this litigation in the Northern District of California or, alternatively, the District of Minnesota. This litigation currently consists of eighteen actions pending in seven districts, as listed on Schedule A.' Since the filing of the motion, the Panel has been notified of 47 related actions.” All…
2Cases cited7 opinions
- In re Xarelto (Rivaroxaban) Products Liability LitigationUnited States Judicial Panel on Multidistrict Litigation · 2014
- In re Fluoroquinolone Products Liability LitigationUnited States Judicial Panel on Multidistrict Litigation · 2015
- In re Androgel Products Liability LitigationUnited States Judicial Panel on Multidistrict Litigation · 2014
- In Re BP P.L.C. Securities LitigationUnited States Judicial Panel on Multidistrict Litigation · 2010
- In re Valsartan N-Nitrosodimethylamine (Ndma) Contamination Prods. Liab. Litig.United States Judicial Panel on Multidistrict Litigation · 2019
2 more not listed; retrieve them via the Exa API.